{"id":"W4415942438","doi":"10.1016/j.annonc.2025.08.749","title":"320P Phase 3 study of neoadjuvant pembrolizumab (Pembro) plus chemotherapy (Chemo) followed by adjuvant pembro for early-stage TNBC: KEYNOTE-522 magnetic resonance imaging (MRI) subgroup analysis","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Jewish General Hospital","funders":"Merck Sharp and Dohme","keywords":"Pembrolizumab; Adjuvant; Exploratory analysis; Neoadjuvant therapy; Magnetic resonance imaging; Subgroup analysis; Adjuvant chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002536825,0.002189037,0.004037067,0.0004724987,0.000472758,0.001523671,0.0009176645,0.001406111,0.00587319],"category_scores_gemma":[0.002385266,0.0008086363,0.006316869,0.0006381228,0.0005597897,0.001165196,0.0007812075,0.003134432,0.0009950526],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0011677,"about_ca_system_score_gemma":0.00157211,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001822854,"about_ca_topic_score_gemma":0.006409855,"domain_scores_codex":[0.9991869,0.0003847532,0.00006076868,0.000165673,0.00007373572,0.0001281064],"domain_scores_gemma":[0.9992275,0.0002150474,0.0001674173,0.0001135008,0.00006815802,0.0002084834],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9619164,0.001917027,0.00284367,0.001108177,0.01278265,0.00005595792,0.00006016304,0.0007471003,0.00339599,0.0001208828,0.002274992,0.01277694],"study_design_scores_gemma":[0.9082181,0.04795761,0.01600676,0.0001465533,0.02064699,0.0001004747,0.0001263423,0.001295602,0.000856797,0.0007620823,0.003805781,0.00007676021],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9632244,0.01719392,0.001673957,0.001756471,0.0014609,0.004248018,0.006352099,0.000220138,0.0038702],"genre_scores_gemma":[0.9758355,0.004931936,0.001905595,0.001841616,0.0006722439,0.004155095,0.004971781,0.00008167909,0.005604579],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00587319,"threshold_uncertainty_score":0.01964784,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03766017846796767,"score_gpt":0.4088319717736823,"score_spread":0.3711717933057146,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}